Inicio > Medicina Interna > La enfermedad cerebrovascular aguda y su relación con la hiperglucemia > Página 4

La enfermedad cerebrovascular aguda y su relación con la hiperglucemia


1. Kavanagh BP, McCowen KC. Clinical practice. Glycemic control in the ICU. NEngl J Med 2010;363:2540–2546.

2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355: 773–778.

3. Barsheshet A, Garty M, Grossman E, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med 2006;166:1613–1619.

4. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426–2432.

5. Kiers L, Davis SM, Larkins R, et al. Stroke topography and outcome in relation to hyperglycemia and diabetes. J Neurol Neurosurg Psychiatry 1992; 55: 263–270.

6. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52 (1):20-8.

7. Kimura K, Sakamoto Y, Iguchi Y, et al. Admission hyperglycemia and serial infarct volume after t-PA therapy in patients with and without early recanalization. J Neurol Sci 2011; 307: 55–59.

8. Fernández Concepción O, Buergo Zuaznábar MA, López Jiménez M. Hiperglicemia post–ictus. Rev Cubana Neurol Neurocir 2012; 2(2):144–9.

9. Brown AM, Tekkok SB, Ransom BR. Glycogen regulation and functional role in mouse white matter. J Physiol 2003; 549:501-12.

10. Sánchez-Abarca LI, Tabernero A, Medina JM. Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia 2001; 36:321-9.

11. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, et al: Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials. A position statemenet of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009;32(1):187-92.

12. Whiting DR, Guariguata L, Weil C, Shaw J: IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94(3):311–21.

13. Anuario estadístico 2012. Prevalencia de diabetes mellitus, hipertensión arterial y asma bronquial según provincia. p97. ISSN 1561-4425.

14. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation. 2010; 121:e46-e215.

15. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2010; 33:S11-61.

16. Bansilal S, Farkouh ME, Fuster V. Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol. 2007; 99:6B-14B.

17. Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, Hoekstra JB. Hyperglycemia: a prothrombotic factor? J Thromb Haemost 2010;8:1663–1669.

18. Marc Rendell, Saraswathi Saiprasad, Alejandro G. Trepp Carrasco, Andjela Drincic. The Future of In-Patient Diabetes Management: Glucose as the Sixth Vital Sign. Expert Review of Endocrinology and Metabolism-Medscape 2013; ISSN: 1744-6651.

19. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.

20. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. World Health Organization, International Society of Hypertension Writing Group. J Hypertension. 2003;21:1983-92.

21. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 14 Jun. 2013;34(28):2159-219.

22. Vital Signs: Awareness and Treatment of Uncontrolled Hypertension Among Adults, United States, 20032010, National Health and Nutrition Examination Survey (NHANES). MMWR Morb Mortal Wkly Rep. 7 Sep. 2012;61:703-9.

23. Encuesta Nacional de Riesgo Cardiovascular 2012. [documento en Internet]. INHEM.; [citado 22 May. 2013]. Disponible en: 2F03%2F2z2FEncuestaNacionaldeRiesgoCardiovascular2012.%2F522462&iwp_ids=52_2462

24. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009; 15:353–69.

25. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein CB, et al: Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34(4):1056-83.

26. Brown DL, Morgenstern LB: Stopping the bleeding in intracerebral hemorrhage. N Engl J Med. 2005;352(8):828-30.

27. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293-8.

28. Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J Med 2000; 342:29-36.

29. Bederson JB, Awad IA, Wiebers DO, Piepgras D, Haley EC Jr, Brott T, et al: Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council, American Heart Association. Stroke 2000;31(11):2742-50.

30. Maki DG, Weinstein RA. Nosocomial infection in the intensive care unit, in Critical Care Medicine. En: Parillo JE, Dellinger, editores. Principles of Diagnosis and Management in the Adult. 2d ed. Philadelphia: Saunders 2001; p 981-1046.

31. Stranders I, Diaman M, E. van Gelde R. Spruijt H, W. R. Twisk J, Heine R, et al. Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes Mellitus. Arch Intern Med. 2004;164(9):982-8.

32. Sinnaeve P, Steg P, Fox K, Van de Werf F, Montalescot G, Granger C, et al; for the GRACE Investigators. Association of Elevated Fasting Glucose With Increased Short-term and 6-Month Mortality in ST-Segment Elevation and Non–ST-Segment Elevation Acute Coronary Syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2009;169(4):402-9.

33. Shimoyama T, Shibazaki K, Kimura K, Uemura J, Shiromoto T, Watanabe M, et al. Admission hyperglycemia causes infarct volume expansion in patients with ICA or MCA occlusion: association of collateral grade on conventional angiography. European Journal of Neurology 2013, 20: 109–116.

34. Inzucchi SE, Siegel M. Glucose control in the ICU-How tight is too tight? N Engl J Med 2009; 360:1346-9.

35. Buchaca Faxas EF, Castillo Carrillo FR, Rodríguez Amador L, Bermúdez Rojas S, Fernández Valdés F, Gutiérrez Rojas AR. Hiperglucemia como indicador pronóstico durante los eventos macrovasculares agudos. Av. Diabetol 2012; 28(2):48-54